Does EVEROLIMUS Cause Interstitial lung disease? 592 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 592 reports of Interstitial lung disease have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 1.5% of all adverse event reports for EVEROLIMUS.
592
Reports of Interstitial lung disease with EVEROLIMUS
1.5%
of all EVEROLIMUS reports
117
Deaths
319
Hospitalizations
How Dangerous Is Interstitial lung disease From EVEROLIMUS?
Of the 592 reports, 117 (19.8%) resulted in death, 319 (53.9%) required hospitalization, and 57 (9.6%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
Yes, Interstitial lung disease is listed as a known adverse reaction in the official FDA drug label for EVEROLIMUS.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which EVEROLIMUS Alternatives Have Lower Interstitial lung disease Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE